DrugPatentWatch Database Preview
Details for New Drug Application (NDA): 020944
Email this page to a colleague
» See Plans and Pricing
NDA 020944 describes JUNIOR STRENGTH ADVIL, which is a drug marketed by Glaxosmithkline and is included in two NDAs. It is available from one supplier. Additional details are available on the JUNIOR STRENGTH ADVIL profile page.
The generic ingredient in JUNIOR STRENGTH ADVIL is ibuprofen. There are sixty-four drug master file entries for this compound. Two hundred and twenty-two suppliers are listed for this compound. Additional details are available on the ibuprofen profile page.
The generic ingredient in JUNIOR STRENGTH ADVIL is ibuprofen. There are sixty-four drug master file entries for this compound. Two hundred and twenty-two suppliers are listed for this compound. Additional details are available on the ibuprofen profile page.
Summary for 020944
| Tradename: | JUNIOR STRENGTH ADVIL |
| Applicant: | Glaxosmithkline |
| Ingredient: | ibuprofen |
| Patents: | 0 |
| Formulation / Manufacturing: | see details |
Medical Subject Heading (MeSH) Categories for 020944
Suppliers and Packaging for NDA: 020944
| Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
|---|---|---|---|---|---|---|---|---|
| CHILDREN'S ADVIL | ibuprofen | TABLET, CHEWABLE;ORAL | 020944 | NDA | Wyeth Consumer Healthcare LLC | 0573-0179 | 0573-0179-20 | 1 BOTTLE in 1 CARTON (0573-0179-20) > 24 TABLET, CHEWABLE in 1 BOTTLE |
| JUNIOR STRENGTH ADVIL | ibuprofen | TABLET, CHEWABLE;ORAL | 020944 | NDA | Wyeth Consumer Healthcare LLC | 0573-0179 | 0573-0179-20 | 1 BOTTLE in 1 CARTON (0573-0179-20) > 24 TABLET, CHEWABLE in 1 BOTTLE |
Profile for product number 001
| Active Rx/OTC/Discontinued: | OTC | Dosage: | TABLET, CHEWABLE;ORAL | Strength | 50MG | ||||
| Approval Date: | Dec 18, 1998 | TE: | RLD: | No | |||||
Profile for product number 002
| Active Rx/OTC/Discontinued: | OTC | Dosage: | TABLET, CHEWABLE;ORAL | Strength | 100MG | ||||
| Approval Date: | Dec 18, 1998 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
